Skip To Main Content
Rachael Barr on Muck Rack

Rachael Barr

As seen in: Science Magazine, Journal of Clinical Virology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rachael

Contact Rachael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Priorities for developing respiratory syncytial virus vaccines in different target populations

|
By Simon B Drysdale, St George’s, Rachael Barr, Christine S. Rollier
| Science Magazine Verified
Abstract The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the virus in the RSV season after vaccination. Recent renewed efforts to develop a vaccine have resulted in about 38 candidate vaccines and monoclonal antibodies now in clinical development.
Open in Who Shared Issue with article?

Change in viral bronchiolitis management in hospitals in the UK after the publication of NICE guideline

|
By Elliott J Carande, Cardiff Road, Andrew Pollard Verified, Rachael Barr
| Journal of Clinical Virology Verified
Publication HistoryPublished online: June 12, 2018Accepted: June 11, 2018; Received in revised form: June 8, 2018; Received: May 2, 2018;
Open in Who Shared Issue with article?
See all 2 articles